Cargando…
Novel humanized monoclonal antibodies for targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX
BACKGROUND: Hypoxia in the tumor microenvironment (TME) is often the main factor in the cancer progression. Moreover, low levels of oxygen in tumor tissue may signal that the first- or second-line therapy will not be successful. This knowledge triggers the inevitable search for different kinds of tr...
Autores principales: | Zatovicova, Miriam, Kajanova, Ivana, Barathova, Monika, Takacova, Martina, Labudova, Martina, Csaderova, Lucia, Jelenska, Lenka, Svastova, Eliska, Pastorekova, Silvia, Harris, Adrian L., Pastorek, Jaromir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811981/ https://www.ncbi.nlm.nih.gov/pubmed/35109923 http://dx.doi.org/10.1186/s40170-022-00279-8 |
Ejemplares similares
-
Carbonic Anhydrase IX—Mouse versus Human
por: Takacova, Martina, et al.
Publicado: (2019) -
Impairment of carbonic anhydrase IX ectodomain cleavage reinforces tumorigenic and metastatic phenotype of cancer cells
por: Kajanova, Ivana, et al.
Publicado: (2020) -
ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non-redundantly to ADAM17
por: Zatovicova, Miriam, et al.
Publicado: (2022) -
Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection
por: Fabianova, Andrea, et al.
Publicado: (2018) -
Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors
por: Sedlakova, Olga, et al.
Publicado: (2014)